addit
respiratori
symptom
patient
present
gastrointestin
complaint
suggest
possibl
faecoor
transmiss
rout
primari
aim
review
establish
incid
time
posit
faecal
sampl
viru
patient
method
systemat
literatur
review
perform
identifi
studi
describ
patient
test
viru
stool
data
extract
concern
natur
test
number
time
posit
sampl
incid
posit
faecal
test
neg
nasopharyng
swab
evid
viabl
faecal
viru
faecoor
transmiss
viru
relev
articl
identifi
combin
result
demonstr
test
faecal
rna
studi
posit
durat
faecal
viral
shed
rang
day
nasopharyng
swab
turn
neg
one
result
remain
posit
day
onset
symptom
insuffici
evid
draw
firm
conclus
proport
case
potenti
transmit
infect
via
faecal
shed
viru
rel
high
rate
posit
test
persist
viru
faecal
sampl
select
patient
research
need
demonstr
much
posit
test
correl
viabl
viru
transmiss
faecoor
rout
may
import
implic
durat
isol
precaut
recommend
individu
undertak
period
isol
protect
equip
health
profession
intervent
procedur
involv
gastrointestin
tract
synthesis
avail
evid
multipl
sourc
clarifi
uncertainti
around
faecal
shed
viru
persist
durat
onset
symptom
neg
nasopharyng
swab
evid
faecoor
transmiss
plausibl
demonstr
one
studi
though
rel
contribut
transmiss
remain
unclear
rapid
progress
pandem
creat
signific
challeng
public
well
healthcar
profession
around
world
knowledg
regard
viru
incub
transmiss
shed
crucial
reduct
new
case
protect
health
care
profession
guidanc
regard
isol
protect
equip
chang
evid
increas
develop
high
incid
cough
fever
well
establish
gastrointestin
symptom
also
well
document
suggest
potenti
faecoor
transmiss
rout
discharg
guidelin
hospit
declar
patient
recov
uk
larg
base
time
either
symptom
onset
posit
test
depend
sever
ill
discharg
destin
european
centr
diseas
prevent
control
ecdc
hand
advoc
need
continu
selfisol
hand
hygien
measur
even
day
postdischarg
base
prolong
viral
shed
faec
respiratori
sampl
evid
may
influenc
recommend
durat
selfisol
well
home
sanit
practic
isol
discharg
use
protect
equip
procedur
involv
gastrointestin
tract
uk
evid
base
recommend
special
gastroenterolog
gastrointestin
endoscopi
gastrointestin
surgeri
requir
may
exposur
risk
viru
shed
faec
despit
viral
rna
detect
air
surfac
sampl
like
toilet
still
unclear
whether
viabl
transmit
infect
rout
primari
aim
review
assess
incid
patient
posit
test
faecal
sampl
viru
time
respect
clinic
cours
onset
symptom
faecal
test
may
posit
secondari
aim
establish
incid
patient
posit
faecal
sampl
neg
respiratori
swab
evid
suggest
faecal
viru
transmit
infect
report
case
studi
patient
evid
viru
faecal
sampl
systemat
identifi
full
text
articl
review
data
extract
comprehens
search
undertaken
per
search
strategi
outlin
literatur
includ
viru
test
faec
medlin
search
find
articl
publish
april
defin
search
term
creat
collabor
author
experienc
gastroenterolog
colorect
surgeri
systemat
review
search
term
reflect
aim
identifi
studi
evid
faecal
includ
clinic
faec
gastrointestin
secret
stool
addit
manual
search
identifi
recent
evid
perform
american
journal
gastroenterolog
ajg
gastroenterolog
gut
lancet
gastroenterolog
hepatolog
databas
centr
evid
base
medicin
cebm
new
england
journal
medicin
nejm
nation
institut
health
care
excel
nice
preprint
publish
april
medrxiv
biorxiv
independ
search
social
media
twitter
author
ss
sd
supplement
articl
articl
describ
patient
faecal
stool
specimen
test
viru
includ
consid
knowledg
gap
exist
articl
consid
regardless
number
age
gender
patient
countri
public
anim
base
studi
articl
without
avail
full
text
exclud
foreign
languag
articl
consid
exclud
unless
necessari
languag
expertis
avail
within
research
group
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
articl
sort
alphabet
author
name
divid
two
review
sg
jp
abstract
review
classifi
two
author
rayyan
web
applic
identifi
full
text
review
process
use
full
text
articl
data
manag
endnot
articl
discuss
review
identifi
final
select
full
text
articl
conflict
solv
supervis
author
necessari
refer
list
review
articl
cross
referenc
identifi
origin
studi
articl
categoris
describ
prisma
flow
chart
final
data
extract
also
carri
two
review
jp
sg
manag
microsoft
excel
file
data
paramet
extract
studi
shown
tabl
final
data
verifi
two
review
jp
sg
conflict
resolut
describ
previous
necessari
countri
public
number
type
patient
studi
type
sampl
taken
faecal
sampl
anal
swab
rtpcr
cultur
number
patient
faecal
sampl
test
number
posit
sampl
time
posit
faecal
swab
symptom
onset
durat
posit
faecal
specimen
neg
nasopharyng
swab
evid
viabl
faecal
viru
faecoor
transmiss
document
studi
tabl
data
paramet
extract
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
medlin
search
identifi
articl
found
databas
overview
select
process
shown
prisma
chart
figur
articl
includ
final
analysi
overview
data
extract
summaris
tabl
studi
china
two
usa
one
itali
korea
vietnam
franc
number
particip
recruit
studi
rang
age
rang
month
year
sampl
collect
consist
either
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
faecal
sampl
anal
rectal
swab
quantit
revers
transcript
polymeras
chain
reaction
rtpcr
test
perform
sampl
detect
viral
rna
indic
faecal
test
specifi
studi
test
done
asymptomat
patient
screen
contact
infect
person
travel
histori
infect
area
predomin
symptom
present
studi
persist
cough
fever
breathless
fewer
patient
report
diarrhoea
vomit
studi
inform
regard
primari
aim
report
faecal
sampl
viru
provid
inform
durat
test
symptom
onset
evid
posit
faecal
sampl
symptom
recoveri
discharg
hospit
neg
nasopharyng
rtpcr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
total
patient
includ
across
studi
test
faecal
viral
rna
posit
faecal
rtpcr
test
occur
time
first
posit
sampl
avail
studi
vari
day
symptom
onset
day
late
posit
test
necessarili
equat
absenc
viru
earlier
ill
may
like
reflect
heterogen
test
pattern
amongst
studi
first
stool
sampl
often
report
late
hospit
admiss
even
discharg
analys
day
hospitalis
symptom
onset
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
similar
discrep
follow
test
test
sampl
found
neg
other
patient
test
posit
faecal
viral
rna
follow
stool
test
show
persist
shed
viru
stool
sampl
neg
nasopharyng
swab
individu
studi
rang
durat
fecal
shed
viral
rna
clearanc
respiratori
sampl
rang
day
patient
day
symptom
onset
none
studi
design
detect
live
viru
faec
except
studi
wang
et
al
stool
specimen
test
studi
pcr
posit
specimen
cultur
live
viru
detect
rapid
review
demonstr
rel
high
incid
persist
stool
posit
rtpcr
neg
nasopharyng
swab
faecal
specimen
select
patient
may
import
implic
regard
measur
prevent
spread
diseas
especi
precaut
recommend
public
protect
equip
health
profession
involv
procedur
intervent
involv
gastrointestin
tract
similar
pattern
viru
isol
stool
faecoor
transmiss
observ
coronavirus
includ
bioaerosol
gener
viral
particl
result
flush
toilet
well
impact
disinfect
also
studi
along
persist
coronavirus
surfac
review
perform
tian
et
al
summaris
evid
import
identifi
gastrointestin
symptom
addit
respiratori
symptom
base
data
china
despit
persist
shed
viru
faec
seem
direct
correl
presenc
sever
gastrointestin
symptom
base
limit
data
avail
review
add
evid
countri
involv
pandem
support
possibl
faecoor
transmiss
risk
health
care
profession
patient
exposur
well
known
specif
high
aerosol
gener
procedur
profession
societi
investig
group
countri
experi
manag
covid
context
gastrointestin
intervent
highlight
risk
individu
endoscopi
depart
need
necessari
precaut
includ
neg
pressur
room
person
protect
equip
review
support
import
measur
given
rel
high
preval
persist
viru
faec
isol
live
viru
confirm
one
studi
proport
case
might
transmit
rout
unclear
due
heterogen
case
select
lack
standardis
studi
design
protocol
area
care
home
may
particularli
vulner
transmiss
infect
rout
recommend
must
take
account
evid
ensur
protect
health
social
care
provid
gener
public
meantim
heterogen
includ
studi
signific
limit
review
formal
assess
due
rapid
review
clearli
identifi
inspect
studi
design
outcom
variabl
patient
number
characterist
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
sampl
time
follow
test
consid
interpret
reliabl
result
heterogen
natur
sampl
may
also
affect
viral
detect
studi
report
faecal
sampl
other
anal
faecal
swab
two
foreign
languag
articl
exclud
due
lack
translat
resourc
durat
viral
shed
faec
mostli
report
day
neg
nasopharyng
swab
continu
day
onset
symptom
patient
posit
sampl
occur
neg
nasopharyng
swab
resolut
patient
symptom
isol
live
viru
stool
specimen
singl
studi
case
support
possibl
faecoor
transmiss
research
need
prove
viral
shed
stool
result
signific
proport
case
transmiss
commun
well
within
care
institut
secondari
care
evid
gener
appropri
precaut
strictli
recommend
protect
healthcar
worker
patient
addit
strict
adher
hand
wash
recommend
home
toilet
sanitari
disinfect
precaut
taken
case
isol
contact
symptomat
covid
case
without
gastrointestin
symptom
recommend
base
limit
evid
possibl
viabl
faecal
viru
excret
precaut
may
need
continu
longer
period
symptom
current
recommend
isol
symptom
ceas
recommend
base
limit
evid
durat
onset
symptom
rtpcr
stool
test
might
still
posit
implic
healthcar
profession
profession
bodi
recommend
protect
equip
endoscop
surgic
procedur
patient
follow
possibl
faecoor
transmiss
born
mind
implic
endoscopi
theatr
disinfect
surfac
procedur
ward
area
patient
care
home
similar
institut
may
need
consid
implic
infect
control
disinfect
light
possibl
faecoor
transmiss
screen
process
patient
due
undergo
investig
intervent
procedur
consid
includ
gastrointestin
symptom
stool
test
futur
preprocedur
questionnair
healthcar
team
manag
patient
gastrointestin
symptom
may
need
consid
possibl
coexist
worsen
symptom
underli
condit
inflammatori
bowel
diseas
futur
studi
viral
shed
infect
consid
standardis
sampl
method
appropri
precaut
laboratori
staff
handl
sampl
situat
clearer
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
studi
design
may
wish
consid
repeat
parallel
sampl
nasopharyng
swab
defin
time
point
may
correl
symptom
serolog
clarifi
effect
neutralis
antibodi
viabl
viru
excret
stool
studi
design
may
benefit
test
stool
sampl
compar
group
could
includ
symptomat
asymptomat
recov
individu
famili
cluster
without
gastrointestin
symptom
may
improv
understand
clinic
public
health
implic
potenti
target
intervent
set
